1. Company Overview

• Founded: 2006 (First hospital established in Gurugram)
• Headquarters: Gurugram, Haryana, India
• Key Leadership: Dr. Dharminder Kumar Nagar (Managing Director)
• Business Model: Paras Healthcare is a clinical specialty-led hospital platform that provides tertiary and quaternary healthcare services, focusing heavily on Tier-2 and Tier-3 cities across North India.
• Network: Operates a growing network of hospitals (around 8 hospitals) with an aggregate capacity exceeding 2,211 beds spread across states like Haryana, Bihar, Uttar Pradesh, Rajasthan, Jharkhand, and Jammu & Kashmir.
• Core Specialties: Major revenue is driven by specialized medical programs such as Cardiac Sciences, Oncology, and Neurology, which consistently account for over 70% to 75% of total operating revenues.

2. Performance

• Operational Footprint: The company has scaled up successfully from ~1,250 beds a few years prior to over 2,200 beds, optimizing occupancy levels across its mature and emerging facilities.
• Expansion Strategy: Focused on deepening its presence in North India with upcoming major capacity additions, including plans for a 300-bed hospital in Gurugram and a 500-bed hospital in Ludhiana, targeting a total capacity of over 3,011 beds.
• Workforce: Employs thousands of healthcare professionals, including over 1,000 experienced doctors and nearly 2,000 nursing and clinical support staff.

3. IPO Details

• IPO Opening Date: October 21, 2026
• IPO Closing Date: October 23, 2026
• Total Issue Size: ₹1,450 crore
  • Fresh Issue: ₹500 crore (72.15 million shares)
  • Offer for Sale (OFS): ₹950 crore (137.08 million shares by existing stakeholders)
• Price Band: ₹660 to ₹693 per equity share
• Face Value: ₹1 per share
• Lot Size: 21 shares (Minimum investment of ₹14,553 at the upper price band for retail investors)
• Tentative Listing Date: October 28, 2026, on both the BSE and NSE
• Use of Proceeds: The fresh issue proceeds are primarily allocated toward the prepayment/repayment of certain outstanding borrowings of the company and its subsidiaries, alongside general corporate purposes.

4. Financial Details

(Based on Restated Consolidated Financial Statements from Regulatory Filings)

• Revenue from Operations:
  • FY 2026: ₹1,629 crore
  • FY 2025: ₹1,314 crore
    (Reflects a robust year-on-year top-line growth of roughly 24%.)
• Profitability (PAT – Profit After Tax):
  • FY 2026: ₹43.83 crore
  • FY 2025: ₹(57.98) crore (previous year net loss)
    (Marking a significant turnaround and profitability surge.)
• Key Ratios (At Upper Price Band):
  • Market Capitalization: ~₹7,498 crore
  • Return on Net Worth (RoNW): ~12.98%
  • Basic Earnings Per Share (EPS): ₹4.34